Literature DB >> 33628511

Topical Bambusa vulgaris Extract Enhances Wound Healing in Cutaneous Leishmaniasis.

Zahra Ghanbarinasab1, Mahnaz Hosseini-Bensenjan1, Elaheh Ziaei Ziabari2, Shiva Aminnia1, Roham Borazjani3, Mohammad Rastegarian Jahromi1, Qasem Asgari4, Bahador Sarkari4,5, Soheil Ashkani-Esfahani1.   

Abstract

BACKGROUND: Bambusa vulgaris (Tabashir) has been shown to have antimicrobial, antioxidant, and anti-inflammatory effects due to the presence of ascorbic acid, vitamin B2, flavonoid, and phenolic compounds which can be beneficial in the process of wound healing. The current study aimed to evaluate the effects of topical Tabashir extract on cutaneous leishmaniasis (CL) caused by Leishmania major in BALB/c mice.
METHODS: Twenty-eight female BALB/c mice (4 weeks old, 18 ± 4 grams) were injected subcutaneously in tail-base with L. major amastigotes. Treatment started when the CL lesions were appeared and continued for 21 days. Mice were then divided into four groups: E1, treated daily with 5% of Tabashir extract gel; E2, treated daily with 10% Tabashir gel; C1, irrigated daily only with normal saline; and C2, received vehicle gel daily. The wounds' sizes were measured every 3 days, using vernier caliper. The volume densities of vessels, collagens, and hair follicles, vessels' length density, and mean diameter were soteriologically determined.
RESULTS: Tabashir enhanced wound closure rate through increasing the number of fibroblasts, collagen bundles, and vessels, according to histomorphometric evaluation while it did not affect the parasitic load. Findings of the in vitro study revealed that the extract has substantial mortality for the Leishmania promastigotes.
CONCLUSION: Topical Tabashir showed promising effects on the healing process of skin wounds caused by CL in this experimental study. Further studies are suggested to find out the molecules which are involved in the healing process.
Copyright © 2021 Zahra Ghanbarinasab et al.

Entities:  

Year:  2021        PMID: 33628511      PMCID: PMC7892243          DOI: 10.1155/2021/7860474

Source DB:  PubMed          Journal:  J Pathog        ISSN: 2090-3057


  8 in total

Review 1.  Leishmaniasis: treatment updates and clinical practice guidelines review.

Authors:  Nathanial K Copeland; Naomi E Aronson
Journal:  Curr Opin Infect Dis       Date:  2015-10       Impact factor: 4.915

Review 2.  Leishmaniasis.

Authors:  Sakib Burza; Simon L Croft; Marleen Boelaert
Journal:  Lancet       Date:  2018-08-17       Impact factor: 79.321

Review 3.  Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.

Authors:  Philippe Minodier; Karine Retornaz; Alexia Horelt; Jean-Marc Garnier
Journal:  Fundam Clin Pharmacol       Date:  2003-04       Impact factor: 2.748

4.  Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival.

Authors:  Miriam A Lynn; Jason Kindrachuk; Alexandra K Marr; Håvard Jenssen; Nelly Panté; Melissa R Elliott; Scott Napper; Robert E Hancock; W Robert McMaster
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

5.  Taurine improves the wound healing process in cutaneous leishmaniasis in mice model, based on stereological parameters.

Authors:  Soheil Ashkani-Esfahani; Fariba Zarifi; Qasem Asgari; Asal Zargari Samadnejad; Shima Rafiee; Ali Noorafshan
Journal:  Adv Biomed Res       Date:  2014-10-07

6.  Preliminary investigation for wound healing and anti-inflammatory effects of Bambusa vulgaris leaves in rats.

Authors:  Santram Lodhi; Alok P Jain; Gopal Rai; Awesh K Yadav
Journal:  J Ayurveda Integr Med       Date:  2016-04-11

7.  Wound healing effects of Bambusa vulgaris leaves.

Authors:  Milind Davane; Basavraj Nagoba
Journal:  J Ayurveda Integr Med       Date:  2016-08-06

Review 8.  Iranian Native Plants on Treatment of Cutaneous Leishmaniosis: A Narrative Review.

Authors:  Elham Moghaddas; Ali Khamesipour; Mehdi Mohebali; Abdolmajid Fata
Journal:  Iran J Parasitol       Date:  2017 Jul-Sep       Impact factor: 1.012

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.